1.Efficacy and safety of losartan in childhood immunoglobulin A nephropathy: a prospective multicenter study
Hyesun HYUN ; Yo Han AHN ; Eujin PARK ; Hyun Jin CHOI ; Kyoung Hee HAN ; Jung Won LEE ; Su Young KIM ; Eun Mi YANG ; Jin Soon SUH ; Jae Il SHIN ; Min Hyun CHO ; Ja Wook KOO ; Kee Hyuck KIM ; Hye Won PARK ; Il Soo HA ; Hae Il CHEONG ; Hee Gyung KANG ; Seong Heon KIM
Childhood Kidney Diseases 2023;27(2):97-104
Purpose:
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers (ARBs) are frequently employed to counteract the detrimental effects of proteinuria on glomerular diseases. However, the effects of ARBs remain poorly examined in pediatric patients with immunoglobulin A (IgA) nephropathy. Herein, we evaluated the efficacy and safety of losartan, an ARB, in pediatric IgA nephropathy with proteinuria.
Methods:
This prospective, single-arm, multicenter study included children with IgA nephropathy exhibiting proteinuria. Changes in proteinuria, blood pressure, and kidney function were prospectively evaluated before and 4 and 24 weeks after losartan administration. The primary endpoint was the difference in proteinuria between baseline and 24 weeks.
Results:
In total, 29 patients were enrolled and received losartan treatment. The full analysis set included 28 patients who received losartan at least once and had pre- and post-urinary protein to creatinine ratio measurements (n=28). The per-protocol analysis group included 22 patients who completed all scheduled visits without any serious violations during the study period. In both groups, the mean log (urine protein to creatinine ratio) value decreased significantly at 6 months. After 24 weeks, the urinary protein to creatinine ratio decreased by more than 50% in approximately 40% of the patients. The glomerular filtration rate was not significantly altered during the observation period.
Conclusions
Losartan decreased proteinuria without decreasing kidney function in patients with IgA nephropathy over 24 weeks. Losartan could be safely employed to reduce proteinuria in this patient population. ClinicalTrials.gov trial registration (NCT0223277)
2.Korea HIV/AIDS Cohort Study: study design and baseline characteristics
Bo Youl CHOI ; Jun Yong CHOI ; Sang Hoon HAN ; Sang Il KIM ; Mee Kyung KEE ; Min Ja KIM ; Shin Woo KIM ; Sung Soon KIM ; Yu Mi KIM ; Nam Su KU ; Jin Soo LEE ; Joo Shil LEE ; Yunsu CHOI ; Kyong Sil PARK ; Joon Young SONG ; Jun Hee WOO ; Moon Won KANG ; June KIM
Epidemiology and Health 2018;40(1):2018023-
The number of persons infected by HIV/AIDS has consistently increased in Korea since the first case of HIV/AIDS infection in 1985 and reached 15,208 by 2016. About 1,100 new patients with HIV/ AIDS infections have emerged every year since 2013. In Korea, the Korea HIV/AIDS Cohort Study was established for the evidenced-based prevention, treatment, and effective management of patients infected with human immunodeficiency virus (HIV) in December 2006. This study monitored 1,438 patients, who accounted for about 10% of all patients with HIV/AIDS in Korea, for 10 years with the following aims: (1) to develop an administrative system for the establishment of a HIV/AIDS cohort-based study; (2) to standardize methodologies and the case report forms; and (3) to standardize multi-cohort data and develop a data cleaning method. This study aims to monitor at least 1,000 patients (excluding those for whom investigation had been completed) per year (estimated number of patients who can be monitored by January 2018: 939). By December 2016, the sex distribution was 93.3% for men, and 6.7% for women (gender ratio, 13.9:1.0), and 98.9% of all participants were Korean. More than 50.0% of the participants were confirmed as HIV positive after 2006. This study reports competitive, long-term research that aimed to develop policies for the prevention of chronic infectious diseases for patients with HIV. The data collected over the last decade will be used to develop indices for HIV treatment and health promotion.
Cohort Studies
;
Communicable Diseases
;
Female
;
Health Promotion
;
HIV
;
Humans
;
Korea
;
Male
;
Methods
;
Sex Distribution
;
Sexually Transmitted Diseases
3.Factors Affecting Activities of Daily Living in Severely Disabled Stroke Patients.
Hyewon JEONG ; Soo Jeong HAN ; Soon Ja JANG ; Jeong Eun LEE
Brain & Neurorehabilitation 2018;11(2):e11-
To investigate factors which affect the activities of daily living (ADL) in severely disabled stroke patients. Medical records of 64 post-stroke patients were reviewed retrospectively. All patients had had rehabilitation for 3 months, and their ADL was assessed using the Korean version of Modified Barthel Index at the time of admission and after 3 months. We also investigated age, onset duration of stroke and the Korean version of Mini-Mental State Examination (K-MMSE) at the time of admission. The ability to roll over, sit, sit to stand, transfer, ambulation, climbing stairs, sitting balance and standing balance were evaluated at the time of admission and after 3 months, either. The factors affecting ADL were K-MMSE and functional ability, such as the ability to roll over, come to sit, sit to stand, sitting and standing balance. The most important factors were the level of K-MMSE and the ability to come to sit. The ability to sit up and the K-MMSE score are the independent factors that can predict the ADL after rehabilitation in severely disabled stroke patient.
Activities of Daily Living*
;
Humans
;
Medical Records
;
Recovery of Function
;
Rehabilitation
;
Retrospective Studies
;
Stroke*
;
Treatment Outcome
;
Walking
4.Korea HIV/AIDS Cohort Study: study design and baseline characteristics
Bo Youl CHOI ; Jun Yong CHOI ; Sang Hoon HAN ; Sang Il KIM ; Mee Kyung KEE ; Min Ja KIM ; Shin Woo KIM ; Sung Soon KIM ; Yu Mi KIM ; Nam Su KU ; Jin Soo LEE ; Joo Shil LEE ; Yunsu CHOI ; Kyong Sil PARK ; Joon Young SONG ; Jun Hee WOO ; Moon Won KANG ; June KIM
Epidemiology and Health 2018;40():e2018023-
The number of persons infected by HIV/AIDS has consistently increased in Korea since the first case of HIV/AIDS infection in 1985 and reached 15,208 by 2016. About 1,100 new patients with HIV/ AIDS infections have emerged every year since 2013. In Korea, the Korea HIV/AIDS Cohort Study was established for the evidenced-based prevention, treatment, and effective management of patients infected with human immunodeficiency virus (HIV) in December 2006. This study monitored 1,438 patients, who accounted for about 10% of all patients with HIV/AIDS in Korea, for 10 years with the following aims: (1) to develop an administrative system for the establishment of a HIV/AIDS cohort-based study; (2) to standardize methodologies and the case report forms; and (3) to standardize multi-cohort data and develop a data cleaning method. This study aims to monitor at least 1,000 patients (excluding those for whom investigation had been completed) per year (estimated number of patients who can be monitored by January 2018: 939). By December 2016, the sex distribution was 93.3% for men, and 6.7% for women (gender ratio, 13.9:1.0), and 98.9% of all participants were Korean. More than 50.0% of the participants were confirmed as HIV positive after 2006. This study reports competitive, long-term research that aimed to develop policies for the prevention of chronic infectious diseases for patients with HIV. The data collected over the last decade will be used to develop indices for HIV treatment and health promotion.
5.Korea HIV/AIDS Cohort Study: study design and baseline characteristics.
Bo Youl CHOI ; Jun Yong CHOI ; Sang Hoon HAN ; Sang Il KIM ; Mee Kyung KEE ; Min Ja KIM ; Shin Woo KIM ; Sung Soon KIM ; Yu Mi KIM ; Nam Su KU ; Jin Soo LEE ; Joo Shil LEE ; Yunsu CHOI ; Kyong Sil PARK ; Joon Young SONG ; Jun Hee WOO ; Moon Won KANG ; June KIM
Epidemiology and Health 2018;40(1):e2018023-
The number of persons infected by HIV/AIDS has consistently increased in Korea since the first case of HIV/AIDS infection in 1985 and reached 15,208 by 2016. About 1,100 new patients with HIV/ AIDS infections have emerged every year since 2013. In Korea, the Korea HIV/AIDS Cohort Study was established for the evidenced-based prevention, treatment, and effective management of patients infected with human immunodeficiency virus (HIV) in December 2006. This study monitored 1,438 patients, who accounted for about 10% of all patients with HIV/AIDS in Korea, for 10 years with the following aims: (1) to develop an administrative system for the establishment of a HIV/AIDS cohort-based study; (2) to standardize methodologies and the case report forms; and (3) to standardize multi-cohort data and develop a data cleaning method. This study aims to monitor at least 1,000 patients (excluding those for whom investigation had been completed) per year (estimated number of patients who can be monitored by January 2018: 939). By December 2016, the sex distribution was 93.3% for men, and 6.7% for women (gender ratio, 13.9:1.0), and 98.9% of all participants were Korean. More than 50.0% of the participants were confirmed as HIV positive after 2006. This study reports competitive, long-term research that aimed to develop policies for the prevention of chronic infectious diseases for patients with HIV. The data collected over the last decade will be used to develop indices for HIV treatment and health promotion.
Cohort Studies*
;
Communicable Diseases
;
Female
;
Health Promotion
;
HIV
;
Humans
;
Korea*
;
Male
;
Methods
;
Sex Distribution
;
Sexually Transmitted Diseases
6.Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma.
Young Bem SE ; Seung Hyun KIM ; Ji Young KIM ; Ja Eun KIM ; Yun Sik DHO ; Jin Wook KIM ; Yong Hwy KIM ; Hyun Goo WOO ; Se Hyuk KIM ; Shin Hyuk KANG ; Hak Jae KIM ; Tae Min KIM ; Soon Tae LEE ; Seung Hong CHOI ; Sung Hye PARK ; Il Han KIM ; Dong Gyu KIM ; Chul Kee PARK
Cancer Research and Treatment 2017;49(2):387-398
PURPOSE: Homeobox (HOX) genes are essential developmental regulators that should normally be in the silenced state in an adult brain. The aberrant expression of HOX genes has been associated with the prognosis of many cancer types, including glioblastoma (GBM). This study examined the identity and role of HOX genes affecting GBM prognosis and treatment resistance. MATERIALS AND METHODS: The full series of HOX genes of five pairs of initial and recurrent human GBM samples were screened by microarray analysis to determine the most plausible candidate responsible for GBM prognosis. Another 20 newly diagnosed GBM samples were used for prognostic validation. In vitro experiments were performed to confirm the role of HOX in treatment resistance. Mediators involved in HOX gene regulation were searched using differentially expressed gene analysis, gene set enrichment tests, and network analysis. RESULTS: The underexpression of HOXA11 was identified as a consistent signature for a poor prognosis among the HOX genes. The overall survival of the GBM patients indicated a significantly favorable prognosis in patients with high HOXA11 expression (31±15.3 months) compared to the prognoses in thosewith low HOXA11 expression (18±7.3 months, p=0.03). When HOXA11 was suppressed in the GBM cell lines, the anticancer effect of radiotherapy and/or temozolomide declined. In addition, five candidate mediators (TGFBR2, CRIM1, TXNIP, DPYSL2, and CRMP1) that may confer an oncologic effect after HOXA11 suppression were identified. CONCLUSION: The treatment resistance induced by the underexpression of HOXA11 can contribute to a poor prognosis in GBM. Further investigation will be needed to confirm the value of HOXA11 as a potential target for overcoming the treatment resistance by developing chemo- or radiosensitizers.
Adult
;
Brain
;
Cell Line
;
Genes, Homeobox
;
Glioblastoma*
;
Humans
;
In Vitro Techniques
;
Microarray Analysis
;
Prognosis*
;
Radiotherapy
7.Higher Blood Pressure Variability in White Coat Hypertension; from the Korean Ambulatory Blood Pressure Monitoring Registry.
In Sook KANG ; Wook Bum PYUN ; Jinho SHIN ; Sang Hyun IHM ; Ju Han KIM ; Sungha PARK ; Kwang Il KIM ; Woo Shik KIM ; Soon Gil KIM ; Gil Ja SHIN
Korean Circulation Journal 2016;46(3):365-373
BACKGROUND AND OBJECTIVES: Blood pressure variability (BPV) was recently shown to be a risk factor of stroke. White coat hypertension (WCH) used to be regarded as innocuous, but one long-term follow-up study reported that WCH increased stroke rate compared to normotension (NT). In this study, we aimed to evaluate the relationship between WCH and BPV. SUBJECTS AND METHODS: We analyzed 1398 subjects from the Korean Ambulatory Blood Pressure Registry, who were divided into NT (n=364), masked hypertension (n=122), white coat hypertension (n=254), and sustained hypertension (n=658) groups. RESULTS: Baseline characteristics were similar among groups. The average real variability (ARV), a highly sensitive BPV parameter, was highest in the WCH group, followed by the sustained hypertension, masked hypertension, and NT groups. The results persisted after being adjusted for covariates. The WCH vs. sustained hypertension results (adjusted mean±standard error) were as follows: 24-h systolic ARV, 22.9±0.8 vs. 19.4±0.6; 24-h diastolic ARV, 16.8±0.6 vs. 14.3±0.5; daytime systolic ARV, 21.8±0.8 vs. 16.8±0.6; and daytime diastolic ARV, 16.2±0.6 vs. 13.4±0.5 (p<0.001 for all comparisons). CONCLUSION: From the registry data, we found that subjects with WCH or masked hypertension had higher BPV than NT. However, long-term follow-up data assessing the clinical influences of WCH on stroke are needed.
Blood Pressure Monitoring, Ambulatory*
;
Blood Pressure*
;
Follow-Up Studies
;
Hypertension
;
Masked Hypertension
;
Risk Factors
;
Stroke
;
White Coat Hypertension*
8.Opportunistic diseases among HIV-infected patients: a multicenter-nationwide Korean HIV/AIDS cohort study, 2006 to 2013.
Youn Jeong KIM ; Jun Hee WOO ; Min Ja KIM ; Dae Won PARK ; Joon Young SONG ; Shin Woo KIM ; Jun Yong CHOI ; June Myung KIM ; Sang Hoon HAN ; Jin Soo LEE ; Bo Youl CHOI ; Joo Shil LEE ; Sung Soon KIM ; Mee Kyung KEE ; Moon Won KANG ; Sang Il KIM
The Korean Journal of Internal Medicine 2016;31(5):953-960
BACKGROUND/AIMS: The frequencies of opportunistic diseases (ODs) vary across countries based on genetic, environmental, and social differences. The Korean HIV/AIDS cohort study was initiated in 2006 to promote research on human immunodeficiency virus (HIV) infection in Korea, and to provide a logistical network to support multicenter projects on epidemiological, clinical, and laboratory aspects of HIV infection. This study evaluated the prevalence of ODs among HIV-infected patients in the era of highly active antiretroviral therapy, and the risk factors associated with ODs. METHODS: The study enrolled 1,086 HIV-infected patients from 19 hospitals. This study examined the baseline data of the HIV/AIDS Korean cohort study at the time of enrollment from December 2006 to July 2013. RESULTS: Candidiasis was the most prevalent opportunistic infection (n = 176, 16.2%), followed by Mycobacterium tuberculosis infection (n = 120, 10.9%), Pneumocystis jirovecii pneumonia (n = 121, 11.0%), cytomegalovirus infection (n = 52, 4.7%), and herpes zoster (n = 44, 4.0%). The prevalence rates of Kaposi’s sarcoma (n = 8, 0.7%) and toxoplasmosis (n = 4, 0.4%) were very low compared with other countries. The risk factors for ODs were a low CD4 T cell count at the time of HIV diagnosis (odds ratio [OR], 1.01; p < 0.01), current smoking (OR, 2.27; p = 0.01), current alcohol use (OR, 2.57; p = 0.04), and a history of tuberculosis (OR, 5.23; p < 0.01). CONCLUSIONS: Using recent Korean nationwide data, this study demonstrated that an important predictor of ODs was a low CD4 T cell count at the time of HIV diagnosis. Tuberculosis remains one of the most important ODs in HIV-infected patients in Korea.
AIDS-Related Opportunistic Infections
;
Antiretroviral Therapy, Highly Active
;
Candidiasis
;
Cell Count
;
Cohort Studies*
;
Cytomegalovirus Infections
;
Diagnosis
;
Herpes Zoster
;
HIV
;
HIV Infections
;
Humans
;
Korea
;
Mycobacterium tuberculosis
;
Opportunistic Infections
;
Pneumocystis jirovecii
;
Pneumonia
;
Prevalence
;
Risk Factors
;
Sarcoma
;
Smoke
;
Smoking
;
Toxoplasmosis
;
Tuberculosis
9.Postpartum Glucose Testing Rates Following Gestational Diabetes Mellitus and Factors Affecting Testing Non-compliance from Four Tertiary Centers in Korea.
Geum Joon CHO ; Jung Joo AN ; Suk Joo CHOI ; Soo Young OH ; Han Sung KWON ; Soon Cheol HONG ; Ja Young KWON
Journal of Korean Medical Science 2015;30(12):1841-1846
The purpose of this study was to investigate postpartum glucose testing rates in patients with gestational diabetes mellitus (GDM) and to determine factors affecting testing non-compliance in the Korean population. This was a retrospective study of 1,686 patients with GDM from 4 tertiary centers in Korea and data were obtained from medical records. Postpartum glucose testing was conducted using a 2-hr 75-g oral glucose tolerance, fasting glucose, or hemoglobin A1C test. Test results were categorized as normal, prediabetic, and diabetic. The postpartum glucose testing rate was 44.9% (757/1,686 patients); and of 757 patients, 44.1% and 18.4% had pre-diabetes and diabetes, respectively. According to the multivariate analysis, patients with a high parity, larger weight gain during pregnancy, and referral from private clinics due to reasons other than GDM treatment were less likely to receive postpartum glucose testing. However, patients who had pharmacotherapy for GDM were more likely to be screened. In this study, 55.1% of patients with GDM failed to complete postpartum glucose testing. Considering the high prevalence of diabetes (18.4%) at postpartum, clinicians should emphasize the importance of postpartum diabetes screening to patients with factors affecting testing noncompliance.
Blood Glucose/*metabolism
;
Diabetes, Gestational/*blood
;
Fasting
;
Female
;
*Glucose Tolerance Test
;
Hemoglobin A, Glycosylated/metabolism
;
Humans
;
Mass Screening/statistics & numerical data
;
Patient Compliance/statistics & numerical data
;
Postpartum Period/*blood
;
Pregnancy
;
Republic of Korea
;
Retrospective Studies
;
Tertiary Care Centers
10.Prevalence of renal dysfunction in patients with cirrhosis according to ADQI-IAC working party proposal.
Yun Jung CHOI ; Jeong Han KIM ; Ja Kyung KOO ; Cho I LEE ; Ji Young LEE ; Jae Hoon YANG ; Soon Young KO ; Won Hyeok CHOE ; So Young KWON ; Chang Hong LEE
Clinical and Molecular Hepatology 2014;20(2):185-191
BACKGROUND/AIMS: A revised classification system for renal dysfunction in patients with cirrhosis was proposed by the Acute Dialysis Quality Initiative and the International Ascites Club Working Group in 2011. The aim of this study was to determine the prevalence of renal dysfunction according to the criteria in this proposal. METHODS: The medical records of cirrhotic patients who were admitted to Konkuk University Hospital between 2006 and 2010 were reviewed retrospectively. The data obtained at first admission were collected. Acute kidney injury (AKI) and chronic kidney disease (CKD) were defined using the proposed diagnostic criteria of kidney dysfunction in cirrhosis. RESULTS: Six hundred and forty-three patients were admitted, of whom 190 (29.5%), 273 (42.5%), and 180 (28.0%) were Child-Pugh class A, B, and C, respectively. Eighty-three patients (12.9%) were diagnosed with AKI, the most common cause for which was dehydration (30 patients). Three patients had hepatorenal syndrome type 1 and 26 patients had prerenal-type AKI caused by volume deficiency after variceal bleeding. In addition, 22 patients (3.4%) were diagnosed with CKD, 1 patient with hepatorenal syndrome type 2, and 3 patients (0.5%) with AKI on CKD. CONCLUSIONS: Both AKI and CKD are common among hospitalized cirrhotic patients, and often occur simultaneously (16.8%). The most common type of renal dysfunction was AKI (12.9%). Diagnosis of type 2 hepatorenal syndrome remains difficult. A prospective cohort study is warranted to evaluate the clinical course in cirrhotic patients with renal dysfunction.
Acute Kidney Injury/*epidemiology/etiology/mortality
;
Adult
;
Aged
;
Cohort Studies
;
Female
;
Hospital Mortality
;
Humans
;
Kidney Failure, Chronic/*epidemiology/etiology/mortality
;
Liver Cirrhosis/complications/*diagnosis
;
Male
;
Middle Aged
;
Prevalence
;
Prospective Studies
;
Severity of Illness Index
;
Survival Rate

Result Analysis
Print
Save
E-mail